Latest France News

Ramsay Health Care posted solid revenue growth driven by its Australian and UK hospital businesses, despite a significant impairment charge impacting net profit. The group advances a multi-year transformation focusing on operational efficiency and capital discipline.

Atlas Arteria’s half-year report for June 2025 reveals stable traffic and revenue growth across its French, German, and US toll road assets, underpinned by disciplined financial management and strategic capital investments.

Atlas Arteria reported a 32.9% drop in statutory net profit for H1 2025 due to a new French tax, yet achieved solid toll revenue and EBITDA growth, maintaining its 2025 distribution guidance.

Atlas Arteria reported a statutory net profit of $73.3 million for H1 2025, impacted by a new tax, while toll revenues rose 8.1%. The company reaffirmed its 2025 distribution guidance of 40 cents per security, supported by strong free cash flow growth.

Atlas Arteria reported an 11.4% rise in revenue for the half year ended June 2025, driven by toll growth across its global portfolio. However, net profit fell 32.9% due to a one-off French tax and ongoing challenges in the US.

Cyclopharm Limited reports a 26% revenue jump to $15.42 million in H1 2025, driven by rapid U.S. expansion and extended patent protections for its Technegas® lung imaging technology.

Lovisa Holdings has reported a robust FY25 with revenue climbing 14.2% and over 160 new stores opened worldwide, signaling strong momentum in the fashion jewellery sector.

Domino’s Pizza Enterprises reported a modest dip in FY25 sales and earnings amid a strategic reset focused on cost efficiency and franchisee support. The company aims to rebuild momentum through targeted reinvestment and operational simplification.

Domino’s Pizza Enterprises reported flat network sales and a modest decline in earnings for FY25, unveiling a comprehensive strategic reset focused on cost reduction, franchisee profitability, and market-specific turnarounds.

Domino’s Pizza Enterprises Limited reported a statutory net loss for FY25, closing 312 underperforming stores and navigating significant leadership changes while declaring an unfranked final dividend.

CleanSpace Holdings posted a robust 26% revenue increase in FY25, turning the corner to positive EBITDA and cash flow in the second half, driven by strong industrial market demand and operational efficiencies.

Polynovo Limited reported a robust 23.3% increase in total revenue for FY25, driven by strong commercial sales growth across the US and international markets. The company is advancing its FDA PMA submission and expanding its global footprint amid strategic product development.